Professional Documents
Culture Documents
☑ Change in Estimates | ☑ Target | Reco Margin improved by ~68bps QoQ despite wage hike reflecting shift towards
digital engineering and support from margin levers (utilization, offshore mix,
Change in Estimates
pyramid).
Current Previous
FY22E FY23E FY22E FY23E
Rating BUY BUY Raised revenue growth guidance to 15-17% YoY USD from 13-15%, We had
Target Price 3,149 3,117 already baked in 17.2% YoY USD growth for FY22.
Sales (Rs. m) 63,873 76,624 63,593 76,292
% Chng. 0.4 0.4
EBITDA (Rs. m) 13,242 15,123 12,552 14,874 LTTS reported strong growth of +4.2% QoQ USD (Ple: 3.7%, Cons:2.7%),
% Chng. 5.5 1.7
EPS (Rs.) 84.1 100.5 79.8 98.8
despite covid led supply side challenges. Growth was broad-based with four
% Chng. 5.4 1.7 out five segments growing 4%-8% QoQ, led by industrial products (+7.8%
QoQ USD). Consistent improvement in EBIT margin for four consecutive
Key Financials - Consolidated quarters led to above pre-covid level margins of 17.3% +68bps QoQ, +220bps
Y/e Mar FY21 FY22E FY23E FY24E higher than our estimates. This is driven by consistent shift towards high
Sales (Rs. m) 54,497 63,873 76,624 89,632
margin digital engineering portfolio.
EBITDA (Rs. m) 10,074 13,242 15,123 17,380
Margin (%) 18.5 20.7 19.7 19.4
PAT (Rs. m) 6,633 8,749 10,551 11,495 LTTS reported healthy deal win TCV with 6 new deals, which includes 2
EPS (Rs.) 63.8 84.1 100.5 109.5 USD25 mn+ deals and 4 deals USD 10 mn+ deals. Management raised revenue
Gr. (%) (19.1) 31.9 19.5 8.9
DPS (Rs.) 20.8 27.5 33.2 54.2 guidance to 15-17% YoY USD from 13-15% led by strong broad-based demand
Yield (%) 0.7 0.9 1.1 1.9 visibility as economies open up (US & Europe) and strong traction due to
RoE (%) 21.3 23.4 24.4 23.1
investments in six strategic growth areas (EACV, 5G, med-tech, digital
RoCE (%) 25.2 29.8 29.0 28.8
EV/Sales (x) 5.3 4.5 3.7 2.0 manufacturing and AI/ML). We have already baked in 17.2%/16.7% revenue
EV/EBITDA (x) 28.6 21.7 18.8 10.4 growth in FY22/23. Our EPS estimates increase by 5.4%/1.7% in FY22/23 led
PE (x) 45.7 34.6 29.0 26.6
P/BV (x) 8.8 7.6 6.6 3.8 by increase in margins & our revenue estimates remains unchanged. Cons
upgrades will be higher (7-9%) as we were already factoring strong revenue
growth. We assume 17.4%/16.4% margins in FY22/23. We continue to value
Key Data LTEH.BO | LTTS IN
LTTS at 30X and arrive at a TP of INR 3149 (earlier: 3117) on Sep23 EPS of INR
52-W High / Low Rs.3,062 / Rs.1,325
Sensex / Nifty 52,904 / 15,854 105 LTTS is currently trading at 34.6X/29X on FY22/23 earnings of INR
Market Cap Rs.306bn/ $ 4,100m
Shares Outstanding 105m
84.1/100.5 respectively with Revenue/EPS CAGR of 17%/25.5% over FY21-23.
3M Avg. Daily Value Rs.1578.63m We have introduced FY24 estimates to capture sustainable strong demand
into our numbers and valuations.
Shareholding Pattern (%)
Promoter’s 74.23 Beat in revenue growth: LTTS reported strong revenue of 205.7 mn USD,
Foreign 8.92 +4.2% QoQ USD above our & cons estimate (Ple: 3.7%, Cons:2.7%), despite
Domestic Institution 5.96
Public & Others 4.13 covid led challenges in this quarter. Revenue share from digital and leading-
Promoter Pledge (Rs bn) - edge technologies continued to grow (54% in 1Q22 vs 52% in 4Q21). Growth
was broad-based with four out five segments growing 4%-8% QoQ, led by
Stock Performance (%) industrial products (+7.8% QoQ USD).
1M 6M 12M
Absolute
Relative
1.7
1.0
8.4
1.6
102.3
37.8
Healthy deal wins: Deal traction was healthy with 6 deal wins of TCV of
USD10mn+ which includes 2 deals with TCV of USD25+. Demand outlook in
both US and Europe continues to remain strong, while in Japan and India
Aniket Pande
aniketpande@plindia.com | 91-22-66322300 decision-making environment is slowly recovering. Management raised
Aditi Patil revenue growth guidance to 15-17% YoY USD from 13-15% led by better
aditipatil@plindia.com | visibility as economies open up (US & Europe) and traction in six strategic
growth areas.
Transportation segment has further Sustained improvement in margins for four consecutive quarters: EBIT
improved to 19.3% EBITDA,
margin of 17.3%, +68 bps QoQ, +517bps YoY, much above our & cons
+250bps, inching towards company
average margins due to focused estimates (Ple: 15%, Cons: 15.6%). Beat in margins despite headwinds from
growth in high margin sub-segments. wage hike this quarter and higher sub-con costs reflects portfolio shift towards
more digital engineering as well as operational efficiencies around pyramid
optimization, cross skilling, productivity improvements and cost optimization.
Utilization (incl. trainees) further increased to all-time high levels of 79.2% (+30
bps QoQ). Employee costs increased by 100bps QoQ partially offset by
decrease in SG&A expenses (60bps QoQ).
LTTS won 6 deals, which includes 2 Hiring plans for FY22: Net headcount addition of 520 employees, 3.2% in
USD25 mn+ deals and 4 deals with
1QFY22 was moderate compared to IT services peers. LTTS plans to hire 450-
TCV of USD10-15mn.
500 employees per quarter in FY22 and at the same time they will focus on
Both the $25 mn+ deals are in optimizing employee pyramid. LTM attrition inched up by 230bps QoQ to
Electric Vehicle space, one with a
14.5% (vs 12.2% in 4Q21 & 11.4% in 1Q21) and is expected to trend upwards.
new age OEM and one with major
Tier 1 company.
Segment wise outlook
Transportation (31.2% of revs, +4.2% QoQ, +19% YoY) - Growth was led by
electrification and platform development across Auto, Trucks and Off-Highway
vehicles. Infrastructure spending plans in US and Europe which seeks to
accelerate nationwide charging network for EV is driving demand. 2) They won
two $25 mn+ deals in auto, both in EV space, one with a new age OEM and
one with major Tier 1. 3) Commercial segments are slowly coming back in
aerospace with spending on digital transformation and connected platforms.
Industrial products (19.5% of revs, +7.5% QoQ, 21% YoY) – 1) All three
sub-segments – electrical, machinery and building automation showed strong
growth. 2) continued demand for product, digitization and personalization, shop
floor automation and digital twin has been driving this strong growth. 3) pickup
in industrial capex and manufacturing activity across US and Europe should
aid momentum in this segment.
Telecom and high tech (22.0% of revs, 3.7% QoQ, 18% YoY): 1) Growth
bounced back driven by semiconductor, consumer electronics and telecom.
LTTS’s recent investments in labs-as-a-service and co-investment in new labs
is helping them drive growth 2) In telecom, there are huge investments being
made in 5G, leveraging open brand technologies, both in traditional telecom as
well as infra OEMs and ISV. LTTS won two $10 million plus deals in this
segment 1Q22.
Medical Devices (11.7% of revs, -0.9% QoQ, +10% YoY) – Medical devices
continues to be soft, but outlook is improving on diagnostic device side.
Demand for digital products, platforms and optimization of manufacturing
processes are key growth drivers in this segment. MedTech is another
emerging area with focus on AI-based diagnostics decision making and
infection management platform. Management’s outlook remains positive and
this segment is expected to bounce back in 2QFY22.
20.9%
20.3%
20.2%
20.2%
20.1%
19.7%
25.0% 78.0
19.0%
18.5%
18.6%
18.4%
18.1%
18.0%
17.7%
17.0%
76.0
16.5%
16.1%
15.9%
15.3%
15.3%
15.3%
20.0% 74.0
72.0
15.0% 70.0
68.0
10.0% 66.0
64.0
5.0% 62.0
60.0
0.0% 58.0
1Q17
2Q17
4Q17
1Q18
3Q18
4Q18
2Q19
3Q19
1Q20
2Q20
4Q20
1Q21
3Q21
4Q21
3Q17
2Q18
1Q19
4Q19
3Q20
2Q21
1Q22
Source: Company, PL
80 15%
8.6%
70 6.4%4.6% 6.9% 6.9%7.5% 6.6% 10%
3.7% 4.6% 3.8% 4.1%3.1% 4.2%
2.4%3.0%
60 5%
-2.2%
50 0%
40 -5%
30 -10%
20 -15%
10 -22.8% -20%
0 -25%
2Q18
4Q18
1Q19
3Q19
1Q20
2Q20
4Q20
2Q21
3Q21
1Q22
1Q18
3Q18
2Q19
4Q19
3Q20
1Q21
4Q21
Source: Company, PL
1Q18
2Q18
3Q18
1Q19
2Q19
4Q19
1Q20
3Q20
4Q20
2Q21
3Q21
1Q22
4Q18
3Q19
2Q20
1Q21
4Q21
Source: Company, PL
56%
55%
55%
54%
54%
53%
53%
51%
60%
50%
49%
47%
45%
44%
44%
44%
41%
41%
41%
50%
40%
40%
39%
38%
37%
37%
36%
34%
32%
40%
30%
28%
27%
27%
27%
30%
20%
10%
0%
1Q18
2Q18
4Q18
2Q19
3Q19
1Q20
3Q20
4Q20
1Q21
2Q21
4Q21
1Q22
3Q18
1Q19
4Q19
2Q20
3Q21
Source: Company, PL
Geography-wise revenues
Fig in USD mn 1QFY22 4QFY21 QoQ gr. 1QFY21 YoY gr.
North America 128.2 121.5 5.5% 104.7 22.5%
Europe 34.6 33.0 4.8% 27.4 26.3%
India 26.5 25.9 2.6% 22.2 19.4%
RoW 16.5 17.4 -5.3% 16.8 -1.8%
Total Revenues 205.7 197.7 4.0% 171.0 20.3%
Headcount Metrics
Employee stats 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22
Total headcount 14777 15140 15913 16789 16787 16,883 16,641 15,902 16,069 16,452 16,972
Billable 13711 14034 14755 15614 15604 15,667 15,481 14,778 14,975 15,335 15,896
Sales & Support 1066 1106 1158 1175 1183 1,216 1,160 1,124 1,094 1,117 1,076
Voluntary attrition 14.9% 14.8% 15.8% 13.4% 13.9% 13.8% 11.4% 10.8% 10.7% 12.2% 14.5%
Net Headcount Add 1192 363 773 876 -2 96 -242 -739 167 383 520
Source: Company, PL
Valuation
Management raised revenue guidance to 15-17% YoY USD from 13-15% led by
strong broad-based demand visibility as economies open up (US & Europe) and
strong traction due to investments in six strategic growth areas (EACV, 5G, med-
tech, digital manufacturing and AI/ML). We have already baked in 17.2%/16.7%
revenue growth in FY22/23. Our EPS estimates increase by 5.4%/1.7% in FY22/23
led by increase in margins & our revenue estimates remains unchanged. Cons
upgrades will be higher (7-9%) as we were already factoring strong revenue growth.
We assume 17.4%/16.4% margins in FY22/23. We continue to value LTTS at 30X
and arrive at a TP of INR 3149 (earlier: 3117) on Sep23 EPS of INR 105 LTTS is
currently trading at 34.6X/29X on FY22/23 earnings of INR 84.1/100.5 respectively
with Revenue/EPS CAGR of 17%/25.5% over FY21-23. We have introduced FY24
estimates to capture sustainable strong demand into our numbers and valuations.
Change in Estimate
Change in Estimates FY22E FY23E FY24E
USD revenues (US$ m)
- New 864 1,008 1,164
- Old 860 1,004 1,164
Change (%) 0.4% 0.4% 0.0%
EBIT Margin
- New 17.4% 16.4% 16.0%
- Old 16.4% 16.1% 16.0%
Change (%) 105 bps 24 bps 0 bps
Recurring EPS - Fully diluted (Rs)
- New 84.1 100.5 109.5
- Old 79.8 98.8 109.5
Change (%) 5.4% 1.7% 0.0%
Source: PL
Financials
Income Statement (Rs m) Balance Sheet Abstract (Rs m)
Y/e Mar FY21 FY22E FY23E FY24E Y/e Mar FY21 FY22E FY23E FY24E
EBIT 7,891 11,130 12,535 14,353 Capital Work In Progress 119 119 119 119
Margin (%) 14.5 17.4 16.4 16.0 Goodwill 5,827 5,827 5,827 5,827
Non-Current Investments 1,644 1,644 1,644 1,644
Net Interest 455 456 40 200 Net Deferred tax assets (511) (511) (511) (511)
Other Income 1,537 1,192 1,600 1,200 Other Non-Current Assets 1,049 1,049 1,049 1,049
(Rs)
No. Date Rating TP (Rs.) Share Price (Rs.)
2975
1 02-Jul-21 BUY 3,117 2,914
Jul - 19
Jul - 20
Jul - 21
Jan - 19
Jan - 20
Jan - 21
7 20-Oct-20 Accumulate 1,860 1,754
8 05-Oct-20 Hold 1,529 1,587
9 01-Oct-20 Hold 1,529 1,611
10 17-Jul-20 Hold 1,362 1,442
ANALYST CERTIFICATION
(Indian Clients)
We/I, Mr. Aniket Pande- MBA, Ms. Aditi Patil- MBA Finance Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this
research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to
the specific recommendation(s) or view(s) in this report.
(US Clients)
The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately
reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific
recommendation or views expressed in this research report.
DISCLAIMER
Indian Clients
Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as “PL”) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for
third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking,
investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com.
This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported
or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security.
The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness
of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made
available or expressed herein or for any omission therein.
Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or
otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor.
Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions
of securities of companies referred to in this report and they may have used the research material prior to publication.
PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document.
PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014
PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities.
PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company.
PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month
immediately preceding the date of publication of the research report.
PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report.
PL or its associates might have received compensation from the subject company in the past twelve months.
PL or its associates might have managed or co-managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any
other assignment in the past twelve months.
PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months.
PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject
company in the past twelve months
PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report.
PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or
other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest
at the time of publication of this report.
It is confirmed that Mr. Aniket Pande- MBA, Ms. Aditi Patil- MBA Finance Research Analysts of this report have not received any compensation from the companies mentioned in the
report in the preceding twelve months
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its
or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity
for the subject company
Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary
to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed
herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest.
PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged
in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an
advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
US Clients
This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s)
preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are
not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or
regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account.
This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act,
1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major
Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted
onward to any U.S. person, which is not the Major Institutional Investor.
In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major
Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo").
Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer.